Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
Bai M
,
Janicic N
,
Trivedi S
,
Quinn SJ
,
Cole DE
,
Brown EM
,
Hendy GN
.
???displayArticle.abstract???
Missense mutations have been identified in the coding region of the extracellular calcium-sensing receptor (CASR) gene and cause human autosomal dominant hypo- and hypercalcemic disorders. The functional effects of several of these mutations have been characterized in either Xenopus laevis oocytes or in human embryonic kidney (HEK293) cells. All of the mutations that have been examined to date, however, cause single putative amino acid substitutions. In this report, we studied a mutant CASR with an Alu-repetitive element inserted at codon 876, which was identified in affected members of families with the hypercalcemic disorders, familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT), to understand how this insertion affects CASR function. After cloning of the Alu-repetitive element into the wild-type CASR cDNA, we transiently expressed the mutant receptor in HEK293 cells. Expression of mutant and wild-type receptors was assessed by Western analysis, and the effects of the mutation on extracellular calcium (Ca2+(o)) and gadolinium (Gd3+(o)) elicited increases in the cytosolic calcium concentration (Ca2+(i)) were examined in fura-2-loaded cells using dual wavelength fluorimetry. The insertion resulted in truncated receptor species that had molecular masses some 30 kD less than that of the wild-type CASR and exhibited no Ca2+(i) responses to either Ca2+(o) or Gd3+(o). A similar result was observed with a mutated CASR truncated at residue 876. However, the Alu mutant receptor had no impact on the function of the coexpressed wild-type receptor. Interestingly, the Alu mutant receptor demonstrated decreased cell surface expression relative to the wild-type receptor, whereas the CASR (A877stop) mutant exhibited increased cell surface expression. Thus, like the missense mutations that have been characterized to date in families with FHH, the Alu insertion in this family is a loss-of-function mutation that produces hypercalcemia by reducing the number of normally functional CASRs on the surface of parathyroid and kidney cells. In vitro transcription of exon 7 of the CASR containing the Alu sequence yielded the full-length mutant product and an additional shorter product that was truncated due to stalling of the polymerase at the poly(T) tract. In vitro translation of the mutant transcript yielded three truncated protein products representing termination in all three reading frames at stop codons within the Alu insertion. Thus sequences within the Alu contribute to slippage or frameshift mutagenesis during transcription and/or translation.
Bai,
Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor.
1996, Pubmed
Bai,
Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor.
1996,
Pubmed
Brown,
Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers.
1991,
Pubmed
Brown,
Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid.
1993,
Pubmed
,
Xenbase
Brownell,
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.
1989,
Pubmed
Chattopadhyay,
The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism.
1996,
Pubmed
Chou,
Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia.
1995,
Pubmed
Cole,
Primary neonatal hyperparathyroidism: a devastating neurodevelopmental disorder if left untreated.
1990,
Pubmed
Dohlman,
Model systems for the study of seven-transmembrane-segment receptors.
1991,
Pubmed
Duksin,
Inhibition of protein glycosylation and selective cytotoxicity toward virally transformed fibroblasts caused by B3-tunicamycin.
1982,
Pubmed
Economou,
The polydeoxyadenylate tract of Alu repetitive elements is polymorphic in the human genome.
1990,
Pubmed
Epstein,
The 3' ends of alu repeats are highly polymorphic.
1990,
Pubmed
Fajtova,
Cytosolic calcium responses of single rMTC 44-2 cells to stimulation with external calcium and potassium.
1991,
Pubmed
Foley,
Familial benign hypercalcemia.
1972,
Pubmed
Garrett,
Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs.
1995,
Pubmed
,
Xenbase
Goldbloom,
Hereditary parathyroid hyperplasia: a surgical emergency of early infancy.
1972,
Pubmed
Heath,
Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.
1996,
Pubmed
,
Xenbase
Ho,
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
1995,
Pubmed
Hope,
GCN4 protein, synthesized in vitro, binds HIS3 regulatory sequences: implications for general control of amino acid biosynthetic genes in yeast.
1985,
Pubmed
Janicic,
Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
1995,
Pubmed
Janicic,
Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16.
1995,
Pubmed
Kerppola,
Analysis of the signals for transcription termination by purified RNA polymerase II.
1990,
Pubmed
Kunkel,
Rapid and efficient site-specific mutagenesis without phenotypic selection.
1985,
Pubmed
Kunkel,
Frameshift mutagenesis by eucaryotic DNA polymerases in vitro.
1986,
Pubmed
Laemmli,
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
1970,
Pubmed
Law,
Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families.
1985,
Pubmed
Macdonald,
Termination and slippage by bacteriophage T7 RNA polymerase.
1993,
Pubmed
Makałowski,
Alu sequences in the coding regions of mRNA: a source of protein variability.
1994,
Pubmed
Marx,
The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds.
1981,
Pubmed
Marx,
An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds.
1982,
Pubmed
Marx,
Familial hypocalciuric hypercalcemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes.
1985,
Pubmed
Marx,
Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism.
1986,
Pubmed
Melton,
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.
1984,
Pubmed
Pearce,
Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells.
1996,
Pubmed
Pearce,
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.
1995,
Pubmed
Pollak,
Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
1993,
Pubmed
Pollak,
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype.
1994,
Pubmed
Resnekov,
RNA polymerase II is capable of pausing and prematurely terminating transcription at a precise location in vivo and in vitro.
1989,
Pubmed
Steinmann,
Neonatal severe primary hyperparathyroidism and alkaptonuria in a boy born to related parents with familial hypocalciuric hypercalcemia.
1984,
Pubmed
Weber,
Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.
1972,
Pubmed
Zuliani,
A high frequency of length polymorphisms in repeated sequences adjacent to Alu sequences.
1990,
Pubmed